Although PTEN downregulation is observed in pancreatic cancer [19] and is associated with poor prognosis and tumor recurrence [33], the mechanisms actively driving PTEN downregulation, especially in cells that make up the tumor microenvironment [22], require further elucidation [34]. This evidence concerns the gene PTEN and neoplasm.